-
Stable Yeast-Based Exendin-4 Expression for Accessible Diabe
2026-08-04
This paper demonstrates a stable system for expressing Exendin-4 in Saccharomyces cerevisiae, offering a cost-effective and scalable platform for producing GLP-1 receptor agonists for type 2 diabetes research and therapeutics. The work establishes foundational protocols and verifies the biological relevance of yeast-expressed Exendin-4, enabling new avenues for affordable insulin sensitivity and beta cell function studies.
-
L-Alanyl-L-Glutamine (B8228): Protocol and GI Research Use
2026-08-04
L-Alanyl-L-Glutamine is a stable, water-soluble dipeptide designed to enhance intestinal mucosa protection and intestinal barrier function in nutritional and GI research models. It is best suited for workflows requiring robust antioxidant system support and precise control of inflammation attenuation during catabolic stress. This product should not be used outside established gastrointestinal or nutritional supplement applications, and long-term solution storage is discouraged.
-
Metoprolol Tartrate: Selective β1 Blockade in Cardiovascular
2026-08-03
Metoprolol Tartrate is a highly selective β1-adrenergic blocking agent used to dissect cardiovascular mechanisms of hypertension, angina, and arrhythmias. Its specificity preserves hematopoietic regeneration, distinguishing it from nonselective β-blockers in post-transplant research. This article details atomic, verifiable facts and integration protocols for precise experimental use.
-
Eicosapentaenoic Acid: Optimizing Cardiovascular Research Wo
2026-08-03
Eicosapentaenoic Acid (EPA) elevates cardiovascular and immunological research through reproducible lipid-lowering and anti-inflammatory effects. This article delivers actionable workflow guidance, protocol enhancements, and troubleshooting strategies for leveraging APExBIO’s high-purity EPA omega-3 fatty acid (SKU B3464) in advanced experimental settings.
-
Cy5 amine (non-sulfonated): Technical Guide for Biomolecule
2026-08-02
Cy5 amine (non-sulfonated) offers a highly photostable, amine-functionalized cyanine dye for covalent labeling of proteins, peptides, and polymers in research workflows that require organic solvent compatibility. This product is not appropriate for direct aqueous labeling or any diagnostic or clinical use, and demands careful solvent handling for reproducible results.
-
Butyrate-Induced Ferroptosis Targets Lung Cancer Stem Cells
2026-08-01
This study reveals that butyrate suppresses lung cancer stemness by triggering ferroptosis through the recruitment of lysosomal Fe2+ and degradation of SLC7A11. The findings highlight a metabolic vulnerability in lung cancer stem cells that can be leveraged for therapeutic strategies targeting iron-dependent oxidative cell death.
-
Eicosapentaenoic Acid: Applied Workflows for Cardiovascular
2026-07-31
Eicosapentaenoic Acid (EPA) delivers reproducible anti-inflammatory and lipid-lowering effects in cardiovascular models, with protocol flexibility for membrane, endothelial, and immunometabolic studies. This article provides advanced workflows, troubleshooting guidance, and real-world insights for leveraging APExBIO’s high-purity EPA omega-3 fatty acid in research.
-
Rifampin as a Molecular Probe: Deep Insights for Bacterial R
2026-07-31
Explore the advanced use of Rifampin, a rifamycin antibiotic, as a molecular probe for dissecting bacterial resistance mechanisms and transcriptional regulation. This article delivers a unique, in-depth analysis connecting mechanistic insight with practical assay design.
-
Pravastatin Sodium: Next-Gen Cholesterol Control for Transla
2026-07-30
Explore the mechanistic, experimental, and translational insights surrounding pravastatin sodium, a benchmark HMG-CoA reductase inhibitor. This article blends biological rationale, protocol parameters, and strategic context, equipping translational researchers to maximize the impact of cholesterol biosynthesis inhibition in both cardiovascular and emerging research domains. Integration with recent botanical-drug interaction studies highlights the evolving landscape of transporter-mediated pharmacokinetics.
-
PRMT5 Inhibition Unveils Glutamine Metabolic Weakness in MNA
2026-07-30
The reference study demonstrates that MYCN-amplified neuroblastoma cells exhibit a pronounced vulnerability to PRMT5 inhibition, linking spliceosomal dysfunction to disrupted glutamine metabolism and epitranscriptomic regulation. These insights provide a mechanistic framework for targeting metabolic dependencies in high-risk neuroblastoma and inform the design of future cancer metabolism research.
-
Tamoxifen: Selective Estrogen Receptor Modulator in Gene Kno
2026-07-29
Tamoxifen’s unique selectivity as a SERM powers precise CreER-mediated gene knockout and advanced cancer research workflows. Explore optimized protocols, troubleshooting insights, and translational bridge strategies—supported by the latest immunological findings and APExBIO’s high-purity formulation.
-
CB-839 (Telaglenastat) in Cancer Metabolism: Protocols & Pit
2026-07-29
CB-839 (Telaglenastat) revolutionizes cancer metabolism research through potent, selective inhibition of glutaminase 1, enabling precise dissection of glutaminolysis and metabolic vulnerabilities in preclinical cancer models. This guide translates recent spliceosomal findings into actionable workflows and troubleshooting strategies, maximizing experimental robustness and translational value.
-
Lypressin Acetate in Translational Vasoconstriction Research
2026-07-28
Lypressin acetate empowers researchers with precise, quantifiable antidiuretic and vasopressor activity, enabling robust disease modeling and emerging antiviral workflows. This guide bridges validated protocol parameters with troubleshooting strategies, enhancing workflow fidelity for diabetes insipidus and SARS-CoV-2 research.
-
Marein Restores Mitoxantrone Sensitivity via ABCG2 Inhibitio
2026-07-28
This study demonstrates that marein, a flavonoid from Coreopsis tinctoria, competitively inhibits the ABCG2 transporter, restoring chemosensitivity to drugs like Mitoxantrone in multidrug-resistant cancer cells. The findings highlight a promising strategy for overcoming ABCG2-mediated drug resistance in oncology research.
-
H3K18 Lactylation Drives NOD2-Linked Pyroptosis in BE Astroc
2026-07-27
Li et al. (2025) reveal that upregulation of histone H3K18 lactylation in astrocytes under bilirubin stress promotes NOD2 transcription, triggering pyroptotic cell death via MAPK and NF-κB pathways. This work clarifies a novel epigenetic-metabolic axis underpinning neuroinflammatory injury in bilirubin encephalopathy, highlighting potential intervention points.